Annika K. Martin and Kelly McNabb to Speak at Complex Litigation eDiscovery Forum (CLEF) Annual Conference May 5-6

Lieff Cabraser partners Annika K. Martin and Kelly McNabb will be featured as distinguished speakers at the Complex Litigation E-Discovery Forum’s (CLEF) annual conference taking place this Thursday and Friday, May 5 – 6, 2022, in Philadelphia, Pennsylvania. Annika will address proportionality on May 5th, while Kelly will speak on “What’s New in Defendants’ ESI Playbook and Strategies?” on

2022-05-05T18:31:14+00:00May 5th, 2022|Firm News|

Thirteen Lieff Cabraser Attorneys Recognized as Lawdragon “500 Leading Plaintiff Consumer Lawyers” for 2022

Lawdragon has published its list of the “500 Leading Plaintiff Consumer Lawyers in America” for 2022, an honor roll that includes Lieff Cabraser partners Donald C. Arbitblit, Kenneth S. Byrd, Elizabeth J. Cabraser, Mark P. Chalos, Paulina do Amaral, Steven E. Fineman, Wendy R. Fleishman, Rachel Geman, Lexi J. Hazam, Richard M. Heimann, Sarah R. London, Annika K. Martin, and Robert J. Nelson. The Lawdragon consumer

2022-04-19T22:08:04+00:00April 19th, 2022|Awards, Firm News|

Plaintiffs Defeat Ford’s Dismissal Attempt in Faulty Truck Brakes Litigation

As reported by Law360, on April 12, 2022, U.S. District Judge Gershwin A. Drain of the Eastern District of Michigan ruled in favor of plaintiffs in refusing Ford’s attempt to dismiss the litigation filed on behalf of hundreds of Ford F-150 pickup truck owners who have experienced sudden and dangerous brake failures in their vehicles.

2022-04-12T20:01:53+00:00April 12th, 2022|Car Accidents & Recalls, Firm News|

SF Opioid Claims Move Forward, Despite Big Pharma’s Ongoing Attempts to Dismiss

As reported by Law360, on April 8, 2022, U.S. District Judge Charles R. Breyer of the Northern District of California issued a ruling that Teva Pharmaceuticals, Allergan, Anda Inc. and other major pharmaceutical companies and distributors allegedly responsible for the manufacturing, transmission, and sale of dangerous, highly addictive and often lethal prescription opioids such as Oxycontin and fentanyl,

2022-04-11T19:11:20+00:00April 11th, 2022|Firm News, Prescription Drug Injuries|

David Rudolph to Discuss Ethical Considerations in Class Actions at 25th Annual ABA National Institute on Class Actions

Lieff Cabraser partner David Rudolph will speak at the American Bar Association’s 25th Annual National Institute on Class Actions on Wednesday, April 13th, 2022 at 10:00 am CT at The Driskill Hotel in Austin, Texas. David will be featured on the panel “Don’t Get Bucked by the Mechanical Bull: Holding onto Adversarial Ethics While Riding Innovations.” The panel

2022-04-11T20:54:24+00:00April 11th, 2022|Firm News|